Cerebellar volume as imaging outcome in progressive multiple sclerosis.

Matilde Inglese Maria PetraccaEnricomaria MorminaAnat AchironRebecca Straus-FarberShmuel MironMichelle FabianStephen KriegerAaron MillerFred LublinMaria Pia Sormani

Published in: PloS one (2017)

Our results suggest a role for cerebellar cortex volume and cerebellar volume as potential short-term imaging metrics to monitor treatment effect in primary-progressive MS clinical trials.

Keyphrases

multiple sclerosis
clinical trial
high resolution
mass spectrometry
ms ms
randomized controlled trial
fluorescence imaging
risk assessment
replacement therapy
climate change